Capital World Investors’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,002,700
Closed -$30M 579
2021
Q4
$30M Hold
8,002,700
﹤0.01% 502
2021
Q3
$41.4M Hold
8,002,700
0.01% 474
2021
Q2
$34.1M Hold
8,002,700
0.01% 489
2021
Q1
$42.5M Hold
8,002,700
0.01% 453
2020
Q4
$43.1M Hold
8,002,700
0.01% 427
2020
Q3
$63.9M Hold
8,002,700
0.01% 371
2020
Q2
$80.1M Hold
8,002,700
0.02% 324
2020
Q1
$21.8M Buy
8,002,700
+1,210,000
+18% +$3.29M 0.01% 385
2019
Q4
$8.15M Hold
6,792,700
﹤0.01% 469
2019
Q3
$10.3M Hold
6,792,700
﹤0.01% 465
2019
Q2
$27.3M Hold
6,792,700
0.01% 403
2019
Q1
$29.2M Hold
6,792,700
0.01% 393
2018
Q4
$39.1M Hold
6,792,700
0.01% 367
2018
Q3
$92.1M Sell
6,792,700
-394,000
-5% -$5.34M 0.02% 321
2018
Q2
$85.3M Buy
7,186,700
+394,000
+6% +$4.68M 0.02% 315
2018
Q1
$76.3M Hold
6,792,700
0.02% 327
2017
Q4
$45.4M Hold
6,792,700
0.01% 360
2017
Q3
$55.6M Hold
6,792,700
0.01% 349
2017
Q2
$30.5M Hold
6,792,700
0.01% 382
2017
Q1
$37.4M Buy
6,792,700
+2,312,214
+52% +$12.7M 0.01% 372
2016
Q4
$18.1M Sell
4,480,486
-120,514
-3% -$488K ﹤0.01% 408
2016
Q3
$32.4M Hold
4,601,000
0.01% 372
2016
Q2
$37.5M Hold
4,601,000
0.01% 358
2016
Q1
$37.4M Hold
4,601,000
0.01% 358
2015
Q4
$55.5M Buy
4,601,000
+2,887,082
+168% +$34.8M 0.02% 336
2015
Q3
$20.5M Buy
1,713,918
+620,168
+57% +$7.42M 0.01% 422
2015
Q2
$20M Buy
+1,093,750
New +$20M 0.01% 442